Nationwide analysis of the breast cancer guidelines adherence in Bulgaria

Study identification

• PURI:
  https://redirect.ema.europa.eu/resource/1000000571
• EU PAS number:
  EUPAS1000000571
• Study ID:
  1000000571
• Official title and acronym:
  Nationwide analysis of the breast cancer guidelines adherence in Bulgaria
• DARWIN EU® study:
  No
• Study countries:
  Bulgaria
• Study description:
  Real-World Data Analysis of Breast Cancer Guidelines Adherence Using Danny Platform;
• Study status:
  Finalised

Research institutions and networks

Institutions

Sqilline Health

Bulgaria

Medical University - Pleven, Bulgaria

Study timelines

Date when funding contract was signed

Planned: 18/09/2023

Actual: 18/09/2023

Study start date

Planned: 01/01/2019

Actual: 01/01/2019

Date of final study report

Planned: 16/04/2024

Actual: 24/04/2024

Sources of funding

No external funding

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable

Other study registration identification numbers and links

Nationwide Analysis of Breast Cancer Guidelines Adherence in Bulgaria